CGEN
Price
$1.54
Change
+$0.02 (+1.32%)
Updated
Dec 24 closing price
Capitalization
143.21M
55 days until earnings call
Intraday BUY SELL Signals
MLTX
Price
$13.87
Change
+$0.13 (+0.95%)
Updated
Dec 24 closing price
Capitalization
982.65M
62 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CGEN vs MLTX

Header iconCGEN vs MLTX Comparison
Open Charts CGEN vs MLTXBanner chart's image
Compugen
Price$1.54
Change+$0.02 (+1.32%)
Volume$62.85K
Capitalization143.21M
MoonLake Immunotherapeutics
Price$13.87
Change+$0.13 (+0.95%)
Volume$536.46K
Capitalization982.65M
CGEN vs MLTX Comparison Chart in %
CGEN
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CGEN vs. MLTX commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEN is a Hold and MLTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (CGEN: $1.54 vs. MLTX: $13.87)
Brand notoriety: CGEN and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEN: 18% vs. MLTX: 26%
Market capitalization -- CGEN: $143.21M vs. MLTX: $982.65M
CGEN [@Biotechnology] is valued at $143.21M. MLTX’s [@Biotechnology] market capitalization is $982.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEN’s FA Score shows that 1 FA rating(s) are green whileMLTX’s FA Score has 1 green FA rating(s).

  • CGEN’s FA Score: 1 green, 4 red.
  • MLTX’s FA Score: 1 green, 4 red.
According to our system of comparison, both CGEN and MLTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEN’s TA Score shows that 3 TA indicator(s) are bullish while MLTX’s TA Score has 5 bullish TA indicator(s).

  • CGEN’s TA Score: 3 bullish, 5 bearish.
  • MLTX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than CGEN.

Price Growth

CGEN (@Biotechnology) experienced а +1.32% price change this week, while MLTX (@Biotechnology) price change was -0.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

CGEN is expected to report earnings on Feb 19, 2026.

MLTX is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($983M) has a higher market cap than CGEN($143M). CGEN YTD gains are higher at: 0.654 vs. MLTX (-74.386). CGEN has higher annual earnings (EBITDA): -32.2M vs. MLTX (-227.94M). MLTX has more cash in the bank: 380M vs. CGEN (86.1M). CGEN has less debt than MLTX: CGEN (2.95M) vs MLTX (75.7M). CGEN has higher revenues than MLTX: CGEN (6.9M) vs MLTX (0).
CGENMLTXCGEN / MLTX
Capitalization143M983M15%
EBITDA-32.2M-227.94M14%
Gain YTD0.654-74.386-1%
P/E Ratio64.00N/A-
Revenue6.9M0-
Total Cash86.1M380M23%
Total Debt2.95M75.7M4%
FUNDAMENTALS RATINGS
CGEN: Fundamental Ratings
CGEN
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
22
SEASONALITY SCORE
1..100
24

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGENMLTX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
60%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
57%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 8 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
65%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
CGEN
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEUCX39.710.18
+0.46%
Principal Equity Income C
IBNCX25.260.07
+0.28%
Nomura Balanced Fund Class C
BSGRX15.940.02
+0.13%
BlackRock Advantage Small Cap Gr R
DHSIX25.74N/A
N/A
Diamond Hill Small Cap I
LSHEX28.10-0.05
-0.18%
Kinetics Spin-Off and Corp Rest No Load

CGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEN has been loosely correlated with NURPF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEN jumps, then NURPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEN
1D Price
Change %
CGEN100%
+1.32%
NURPF - CGEN
46%
Loosely correlated
N/A
ASPHF - CGEN
41%
Loosely correlated
N/A
ORMP - CGEN
40%
Loosely correlated
+6.78%
ABCL - CGEN
38%
Loosely correlated
+0.81%
MLTX - CGEN
37%
Loosely correlated
+0.95%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+0.95%
KALA - MLTX
85%
Closely correlated
+12.32%
IOBT - MLTX
75%
Closely correlated
+5.50%
NEVPF - MLTX
70%
Closely correlated
N/A
XNCR - MLTX
50%
Loosely correlated
-0.13%
NUVL - MLTX
48%
Loosely correlated
+0.89%
More